A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema

QJM: An International Journal of Medicine

Volumn 109, Issue 5, 2016, Pages 331-336

  Stolk, Jan ^a   Broekman, W ^a   Mauad, T ^b   Zwaginga, J J ^a   Roelofs, H ^a   Fibbe, W E ^a   Oostendorp, J ^a   Bajema, I ^a   Versteegh, M I M ^a   Taube, C ^a   Hiemstra, P S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG EMPHYSEMA; LUNG PARENCHYMA; LUNG VOLUME; MALE; MIDDLE AGED; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; ANGIOGENESIS; AUTOTRANSPLANTATION; BONE MARROW CELL; CELL PROLIFERATION; CLINICAL TRIAL; CYTOLOGY; ENDOTHELIUM CELL; FOLLOW UP; LUNG; LUNG RESECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STROMA CELL; SURGERY; TRANSPLANTATION; TREATMENT OUTCOME; VASCULARIZATION;

PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1;

ADULT; AGED; BONE MARROW CELLS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1; PNEUMONECTOMY; PROSPECTIVE STUDIES; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; STROMAL CELLS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84965050283     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcw001     Document Type: Article

References (18)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7.
2. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13:392-402.
3. Petrella F, Acocella F, Barberis M, Bellomi M, Brizzola S, Donghi S, et al. Airway fistula closure after stem-cell infusion. N Engl J Med 2014; 372:96-7.
4. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371:1579-86.
5. Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, et al. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with crohn's disease. Gastroenterology 2015; 149:918-27.
6. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Matsuyama A, Shiono H, et al. Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med 2006; 174:1199-205.
7. Zhen G, Liu H, Gu N, Zhang H, Xu Y, Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 2008; 13:3415-22.
8. Stolk J, Versteegh MI, Montenij LJ, Bakker ME, Grebski E, Tutic M, et al. Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J 2007; 29:1138-43.
9. Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010; 59:1662-9.
10. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143:1590-8.
11. Kim V, Kretschman DM, Sternberg AL, DeCamp MM Jr, Criner GJ. Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med 2012; 186:1109-16.
12. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567-75.
13. Thomashow MA, Shimbo D, Parikh MA, Hoffman EA, Vogel-Claussen J, Hueper K, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multi-ethnic study of atherosclerosis chronic obstructive pulmonary disease study. Am J Respir Crit Care Med 2013; 188:60-8.
14. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, et al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax 2012; 67:1067-74.
15. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29:88-97.
16. Privratsky J, Newman P. PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res 2014; 355:607-19.
17. Gratzinger D, Canosa S, Engelhardt B, Madri JA. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. Faseb J 2003; 17:1458-69.
18. Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, et al. Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem 2010; 285:6515-2.